Clostridium scindens
Selected indexed studies
- Clostridium Scindens Protects Against Vancomycin-Induced Cholestasis and Liver Fibrosis by Activating Intestinal FXR-FGF15/19 Signaling. (Adv Sci (Weinh), 2025) [PMID:39680750]
- Gut Bacteroides ovatus ameliorates renal fibrosis by promoting the production of HDCA through upregulation of Clostridium scindens. (Cell Rep, 2024) [PMID:39392759]
- Clostridium scindens: history and current outlook for a keystone species in the mammalian gut involved in bile acid and steroid metabolism. (FEMS Microbiol Rev, 2025) [PMID:40307670]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Gut Bacteroides ovatus ameliorates renal fibrosis by promoting the production of HDCA through upregulation of Clostridium scindens. (2024) pubmed
- Clostridium Scindens Protects Against Vancomycin-Induced Cholestasis and Liver Fibrosis by Activating Intestinal FXR-FGF15/19 Signaling. (2025) pubmed
- Clostridium scindens: history and current outlook for a keystone species in the mammalian gut involved in bile acid and steroid metabolism. (2025) pubmed
- Clostridium scindens attenuates acute kidney injury by producing indole-3-acetic acid. (2025) pubmed
- Clostridium scindens metabolites trigger prostate cancer progression through androgen receptor signaling. (2023) pubmed
- Clostridium scindens : an endocrine keystone species in the mammalian gut. (2024) pubmed
- Clostridium scindens exacerbates experimental necrotizing enterocolitis via upregulation of the apical sodium-dependent bile acid transporter. (2024) pubmed
- Clostridium scindens promotes gallstone formation by inducing intrahepatic neutrophil extracellular traps through CXCL1 produced by colonic epithelial cells. (2025) pubmed
- Clostridium scindens secretome suppresses virulence gene expression of Clostridioides difficile in a bile acid-independent manner. (2023) pubmed
- Review: microbial transformations of human bile acids. (2021) pubmed